drugset / Trial / NCT02072408
Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
Phase 4
Completed
46 enrolled
Samsung Medical Center
Bayer · collabKim's Eye Hospital · collabSeoul National University Bundang Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of aflibercept for treatment of polypoidal choroidal vasculopathy without active polyp.
Timeline
- Start
- 2014-02
- Primary completion
- 2017-11-02
- Completion
- 2017-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | 2 mg | Intravitreal |
| Background | Verteporfin | Other / unclassified | — | — |